BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 17915401)

  • 1. Medical device safety: FDA's postmarket transformation initiative.
    Schultz D
    Food Drug Law J; 2007; 62(3):593-6. PubMed ID: 17915401
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical devices post-approval studies program: vision, strategies, challenges and opportunities.
    Marinac-Dabic D; Bonhomme M; Loyo-Berrios N; Gross T; Ciperson R; Gardner S; Marcarelli M
    Food Drug Law J; 2007; 62(3):597-604. PubMed ID: 17915402
    [No Abstract]   [Full Text] [Related]  

  • 4. MedWatch. FDA's 'heads up' on medical product safety.
    Henkel J
    FDA Consum; 1998; 32(6):10-2, 15. PubMed ID: 9854445
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical device recalls from 2004 to 2006: a focus on Class I recalls.
    Villarraga ML; Guerin HL; Lam T
    Food Drug Law J; 2007; 62(3):581-92. PubMed ID: 17915400
    [No Abstract]   [Full Text] [Related]  

  • 7. The Safe Medical Devices Act of 1990--FDA. Notice.
    Fed Regist; 1991 Apr; 56(66):14111-3. PubMed ID: 10111151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FDA and drug safety: a proposal for sweeping changes.
    Furberg CD; Levin AA; Gross PA; Shapiro RS; Strom BL
    Arch Intern Med; 2006 Oct; 166(18):1938-42. PubMed ID: 17030825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not enough warning. GAO report finds FDA's medical device monitoring lacking.
    Hensley S
    Mod Healthc; 1997 Mar; 27(10):102, 104. PubMed ID: 10165267
    [No Abstract]   [Full Text] [Related]  

  • 11. What you should know about device recalls.
    OR Manager; 2002 Apr; 18(4):21. PubMed ID: 11962164
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk assessment and management as related to evaluation of medical devices: a view from the FDA.
    Callahan TJ; Marlowe DE
    J Long Term Eff Med Implants; 1993; 3(4):269-76. PubMed ID: 10172029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilities' responsibilities after notification of a medical device hazard or recall.
    Health Devices; 2004 Sep; 33(9):339. PubMed ID: 15532863
    [No Abstract]   [Full Text] [Related]  

  • 14. The U.S. FDA's involvement in the development and utilization of D11.40's standards on rubber consumer products.
    Lin CS; Herman C
    Stand News; 2003 Jul; 31(7):38-41. PubMed ID: 12882219
    [No Abstract]   [Full Text] [Related]  

  • 15. Postmarket surveillance for medical devices: America's new strategy.
    Normand SL; Hatfield L; Drozda J; Resnic FS
    BMJ; 2012 Oct; 345():e6848. PubMed ID: 23060660
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges in regulating breakthrough medical devices.
    Muni NI; Gross TP; Boam AB; Wang S; Zuckerman BD
    Food Drug Law J; 2005; 60(2):137-42. PubMed ID: 16097092
    [No Abstract]   [Full Text] [Related]  

  • 17. Device tracking: user facility responsibilities.
    Shepherd N
    J Clin Eng; 1993; 18(5):441-52. PubMed ID: 10129809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework?
    Basile EM; Lorell BH
    Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031
    [No Abstract]   [Full Text] [Related]  

  • 19. Achieving medical device safety in an era of globalization.
    Meritz JK; White TL
    Food Drug Law J; 2008; 63(3):647-55. PubMed ID: 19031664
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA's cloning report bypasses ethics, exposes European dilemma.
    Vermij P
    Nat Biotechnol; 2007 Jan; 25(1):7-8. PubMed ID: 17211377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.